<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>CARBASTAT- carbachol injection, solution </strong><br>Novartis Ophthalmics<br></p></div>
<h1>Carbastat<span class="Sup">®</span>
</h1>
<div class="Contents">
<div class="Section">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-2"></a><p></p>
<h1></h1>
<p class="First"><span class="Bold">C</span><span class="Bold">arbasta</span><span class="Bold">t</span><span class="Bold"><span class="Sup">®</span></span></p>
<p>(CARBACHOL INTRAOCULAR SOLUTION, USP) 0.01%</p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-3"></a><p></p>
<h1><span class="Bold">DESCRIPTION </span></h1>
<p class="First">CARBASTAT<span class="Sup">®</span><span class="Bold"> </span>(Carbachol Intraocular Solution, USP) 0.01% is a sterile balanced salt solution of carbachol for intraocular injection. The active ingredient is represented by the structural formula:</p>
<p><img alt="Image from Drug Label Content" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=048AF9C6-4866-4500-9914-CD7071A19B63&amp;name=carbastat-figure-01.jpg"></p>
<p>Established name: Carbachol</p>
<p>Chemical name: Ethanaminium, 2-[(aminocarbonyl)oxy]-<span class="Italics">N,N,N</span> -trimethyl-, chloride.</p>
<p>Each mL contains: Active: Carbachol 0.01%.</p>
<p>Inactive: Sodium chloride 0.64%, potassium chloride 0.075%, calcium chloride dihydrate 0.048%, magnesium chloride hexahydrate 0.03%, sodium acetate trihydrate 0.39%, sodium citrate dihydrate 0.17%, sodium hydroxide and/or hydrochloric acid to adjust pH (5.0-7.5) and water for injection USP.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-4"></a><p></p>
<h1><span class="Bold">CLINICAL PHARMACOLOGY</span></h1>
<p class="First">Carbachol is a potent cholinergic (parasympathomimetic) agent which produces constriction of the iris and ciliary body resulting in reduction in intraocular pressure. The exact mechanism by which carbachol lowers intraocular pressure is not precisely known.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-5"></a><p></p>
<h1><span class="Bold">INDICATIONS AND USAGE</span></h1>
<p class="First">Intraocular use for obtaining <span class="product-label-link" type="condition" conceptid="435279" conceptname="Tonic pupillary reaction">miosis</span> during surgery. In addition, Carbastat<span class="Sup">®</span> (Carbachol Intraocular Solution USP) reduces the intensity of intraocular pressure elevation in the first 24 hours after <span class="product-label-link" type="condition" conceptid="375545" conceptname="Cataract">cataract</span> surgery.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-6"></a><p></p>
<h1><span class="Bold">CONTRAINDICATIONS</span></h1>
<p class="First">Should not be used in those persons showing <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to any of the components of this preparation.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="section-7"></a><p></p>
<h1><span class="Bold">WARNINGS</span></h1>
<p class="First">For single-dose intraocular use only. Discard unused portion. Intraocular carbachol 0.01% should be used with caution in patients with acute <span class="product-label-link" type="condition" conceptid="316139" conceptname="Heart failure">cardiac failure</span>, bronchial <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthma</span>, <span class="product-label-link" type="condition" conceptid="4027663" conceptname="Peptic ulcer">peptic ulcer</span>, <span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">hyperthyroidism</span>, G.I. spasm, <span class="product-label-link" type="condition" conceptid="194406" conceptname="Urinary tract obstruction">urinary tract obstruction</span> and Parkinson's disease.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="section-8"></a><p></p>
<h1><span class="Bold">PRECAUTIONS</span></h1>
<div class="Section" data-sectionCode="34083-6">
<a name="section-8.1"></a><p></p>
<h2><span class="Bold">Carcinogenesis</span></h2>
<p class="First">Studies in animals to evaluate the carcinogenic potential have not been conducted.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="section-8.2"></a><p></p>
<h2>
<span class="Bold">Pregnancy: </span>Category C.<span class="Bold"> </span>
</h2>
<p class="First">There are no adequate and well controlled studies in pregnant women. Carbastat<span class="Sup">®</span>  should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.</p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="section-8.3"></a><p></p>
<h2><span class="Bold">Nursing Mothers </span></h2>
<p class="First">It is not known if this medication is excreted in breast milk. Exercise caution when administering to a nursing woman.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="section-8.4"></a><p></p>
<h2><span class="Bold">Pediatric Use </span></h2>
<p class="First">Safety and efficacy in pediatric patients have not been established.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-9"></a><p></p>
<h1><span class="Bold">ADVERSE REACTIONS</span></h1>
<div class="Section" data-sectionCode="42229-5">
<a name="section-9.1"></a><p></p>
<h2><span class="Bold">Ocular </span></h2>
<p class="First"><span class="product-label-link" type="condition" conceptid="378752" conceptname="Corneal opacity">Corneal clouding</span>, persistent <span class="product-label-link" type="condition" conceptid="372635" conceptname="Corneal degeneration">bullous keratopathy</span>, <span class="product-label-link" type="condition" conceptid="378414" conceptname="Retinal detachment">retinal detachment</span> and postoperative <span class="product-label-link" type="condition" conceptid="4274964" conceptname="Iritis">iritis</span> following <span class="product-label-link" type="condition" conceptid="375545" conceptname="Cataract">cataract</span> extraction have been reported.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-9.2"></a><p></p>
<h2><span class="Bold">Systemic </span></h2>
<p class="First">Side effects such as <span class="product-label-link" type="condition" conceptid="318566" conceptname="Flushing">flushing</span>, <span class="product-label-link" type="condition" conceptid="138565" conceptname="Hyperhidrosis">sweating</span>, <span class="product-label-link" type="condition" conceptid="23325" conceptname="Heartburn">epigastric distress</span>, <span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">abdominal cramps</span>, tightness in urinary bladder, and <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span> have been reported with topical or systemic application of carbachol.</p>
</div>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-10"></a><p></p>
<h1><span class="Bold">DOSAGE AND ADMINISTRATION</span></h1>
<p class="First">Aseptically remove the sterile vial from the <span class="product-label-link" type="condition" conceptid="443720" conceptname="Blister">blister</span> package by <span class="product-label-link" type="condition" conceptid="4032013" conceptname="Desquamation">peeling</span> the backing paper and dropping the vial onto a sterile tray. Withdraw the contents into a dry sterile syringe, and replace the needle with an atraumatic cannula prior to intraocular irrigation. No more than one-half milliliter should be gently instilled into the anterior chamber for the production of satisfactory <span class="product-label-link" type="condition" conceptid="435279" conceptname="Tonic pupillary reaction">miosis</span>. It may be instilled before or after securing sutures. <span class="product-label-link" type="condition" conceptid="435279" conceptname="Tonic pupillary reaction">Miosis</span> is usually maximal within two to five minutes after application.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-11"></a><p></p>
<h1><span class="Bold">HOW SUPPLIED</span></h1>
<p class="First">CARBASTAT (Carbachol Intraocular Solution, USP) 0.01%</p>
<p>1.5 mL sterile glass vials in cartons of 12 (12 x 1.5 mL)</p>
<p>NDC 58768-735-12</p>
<p>Store at controlled room temperature 15°-30°C (59°-86°F).</p>
<p><span class="Bold">Rx only</span></p>
<p><span class="Bold"> </span></p>
<p>Manufactured by OMJ Pharmaceuticals, Inc., </p>
<p>San Germán, P.R. 00683</p>
<p>for Novartis Ophthalmics</p>
<p>Duluth, GA 30097</p>
<p>5007-D</p>
<p>March, 2001</p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>CARBASTAT 		
					</strong><br><span class="contentTableReg">carbachol injection, solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:58768-735</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAOCULAR</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>Carbachol</strong> (Carbachol) </td>
<td class="formItem"></td>
<td class="formItem">0.1 mg  in 1 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>calcium chloride dihydrate</strong></td>
<td class="formItem">0.481 mg  in 1 mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>hydrochloric acid</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>magnesium chloride hexahydrate</strong></td>
<td class="formItem">0.3 mg  in 1 mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>potassium chloride</strong></td>
<td class="formItem">0.75 mg  in 1 mL</td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>sodium acetate trihydrate</strong></td>
<td class="formItem">3.9 mg  in 1 mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>Sodium chloride</strong></td>
<td class="formItem">6.4 mg  in 1 mL</td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>sodium citrate dihydrate</strong></td>
<td class="formItem">1.7 mg  in 1 mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>sodium hydroxide</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>water</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:58768-735-12</td>
<td class="formItem">12  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">1.5 mL in 1 VIAL, GLASS</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Novartis Ophthalmics</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 9/2006<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>048AF9C6-4866-4500-9914-CD7071A19B63</div>
<div>Set id: 048AF9C6-4866-4500-9914-CD7071A19B63</div>
<div>Version: 1</div>
<div>Effective Time: 20060919</div>
</div>
</div> <div class="DistributorName">Novartis Ophthalmics</div></p>
</body></html>
